Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: A longitudinal case-cohort study

American Journal of Obstetrics and Gynecology

Volumn 214, Issue 5, 2016, Pages 629.e1-629.e17

  Korzeniewski, Steven J ^a,b,c   Romero, Roberto ^a,b,c,d   Chaiworapongsa, Tinnakorn ^a,b   Chaemsaithong, Piya ^a,b   Kim, Chong Jai ^a,e   Kim, Yeon Mee ^a,f,g   Kim, Jung Sun ^a,h   Yoon, Bo Hyun ^a,i   Hassan, Sonia S ^a,b   Yeo, Lami ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e University of Ulsan College of Medicine   (South Korea)

^f Inje University College of Medicine   (South Korea)

^g Kyungpook National University School of Medicine   (South Korea)

^h Samsung Medical Center   (South Korea)

ⁱ Seoul National University   (South Korea)

Author keywords

acute atherosis; basal plate; fetal death; intervillous fibrin; persistent muscularization of the arteries; placental pathology; preeclampsia; preterm delivery; small for gestational age; soluble Flt 1; syncytial knot; villous infarction

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL PLASMA; NULLIPARA; PLACENTA; PLACENTA INSUFFICIENCY; PLACENTAL DELIVERY; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMALL FOR DATE INFANT; VEIN PUNCTURE; BLOOD; GESTATIONAL AGE; PATHOLOGY; PREMATURITY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; VASCULARIZATION; YOUNG ADULT;

ADULT; BIOMARKERS; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; LIKELIHOOD FUNCTIONS; LONGITUDINAL STUDIES; PLACENTA; PLACENTA GROWTH FACTOR; PREGNANCY; PREMATURE BIRTH; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 84975784600     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.11.015     Document Type: Article

References (186)

1. J. Hustin, and J.P. Schaaps Echographic [corrected] and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy Am J Obstet Gynecol 157 1987 162 168
2. J. Hustin, J.P. Schaaps, and R. Lambotte Anatomical studies of the utero-placental vascularization in the first trimester of pregnancy Troph Res 1988 1988 49 60
3. E. Jauniaux, D. Jurkovic, and S. Campbell In vivo investigations of the anatomy and the physiology of early human placental circulations Ultrasound Obstet Gynecol 1 1991 435 445
4. R. Jaffe, and S.L. Warsof Transvaginal color Doppler imaging in the assessment of uteroplacental blood flow in the normal first-trimester pregnancy Am J Obstet Gynecol 164 1991 781 785
5. E. Jauniaux, D. Jurkovic, S. Campbell, and J. Hustin Doppler ultrasonographic features of the developing placental circulation: correlation with anatomic findings Am J Obstet Gynecol 166 1992 585 587
6. R. Jaffe, and J.R. Woods Jr. Color Doppler imaging and in vivo assessment of the anatomy and physiology of the early uteroplacental circulation Fertil Steril 60 1993 293 297
7. M. Coppens, P. Loquet, M. Kollen, F. De Neubourg, and P. Buytaert Longitudinal evaluation of uteroplacental and umbilical blood flow changes in normal early pregnancy Ultrasound Obstet Gynecol 7 1996 114 121
8. L.T. Merce, M.J. Barco, and S. Bau Color Doppler sonographic assessment of placental circulation in the first trimester of normal pregnancy J Ultrasound Med 15 1996 135 142
9. L. Valentin, P. Sladkevicius, R. Laurini, H. Soderberg, and K. Marsal Uteroplacental and luteal circulation in normal first-trimester pregnancies: Doppler ultrasonographic and morphologic study Am J Obstet Gynecol 174 1996 768 775
10. A. Kurjak, and S. Kupesic Doppler proof of the presence of intervillous circulation Ultrasound Obstet Gynecol 7 1996 463 464
11. R. Jaffe, E. Jauniaux, and J. Hustin Maternal circulation in the first-trimester human placenta-myth or reality? Am J Obstet Gynecol 176 1997 695 705
12. G.J. Burton, E. Jauniaux, and A.L. Watson Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited Am J Obstet Gynecol 181 1999 718 724
13. E. Jauniaux, and G.J. Burton Oxygen delivery at the deciduoplacental interface R. Pijnenborg, I. Brosens, R. Romero, Placental bed disorders: basic science and its translation to obstetrics 2010 Cambridge University Press Cambridge (United Kingdom)
14. K. Bernirschke, G.J. Burton, and R.N. Baergen Early development of the human placenta. Pathology of the Human Placenta 2012 Springer Cambridge (United Kingdom)
15. I. Brosens, W.B. Robertson, and H.G. Dixon The physiological response of the vessels of the placental bed to normal pregnancy J Pathol Bacteriol 93 1967 569 579
16. R. Pijnenborg, G. Dixon, W.B. Robertson, and I. Brosens Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy Placenta 1 1980 3 19
17. R. Pijnenborg, J.M. Bland, W.B. Robertson, G. Dixon, and I. Brosens The pattern of interstitial trophoblastic invasion of the myometrium in early human pregnancy Placenta 2 1981 303 316
18. R. Pijnenborg, J.M. Bland, W.B. Robertson, and I. Brosens Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy Placenta 4 1983 397 413
19. J.J. Brosens, R. Pijnenborg, and I.A. Brosens The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature Am J Obstet Gynecol 187 2002 1416 1423
20. I. Brosens Unraveling the anatomy R. Pijnenborg, R. Romero, Placental bed disorders: basic science and its translation to obstetrics 2010 Cambridge University Press Cambridge (United Kingdom)
21. Y. Khong, and I. Brosens Defective deep placentation Best Pract Res Clin Obstet Gynaecol 25 2011 301 311
22. I. Brosens, R. Pijnenborg, L. Vercruysse, and R. Romero The "great obstetrical syndromes" are associated with disorders of deep placentation Am J Obstet Gynecol 204 2011 193 201
23. Y. Wang, and S. Zhao Chapter 2, Placental blood circulation. Vascular biology of the placenta 2010 Morgan and Claypool Life Sciences San Rafael (CA)
24. H.H. Kay, M.D. Nelson, and Y. Wang Development and anatomy of the human placenta. The placenta: from development to disease 2011 Blackwell Publishing Ltd Singapore
25. K.E. Brett, Z.M. Ferraro, J. Yockell-Lelievre, A. Gruslin, and K.B. Adamo Maternal-fetal nutrient transport in pregnancy pathologies: the role of the placenta Int J Mol Sci 15 2014 16153 16185
26. A.M. Carter Placental gas exchange and the oxygen supply to the fetus Compr Physiol 5 2015 1381 1403
27. M. Maqueo, J. Chavezazuela, and M. Dosaldelavega Placental pathology in eclampsia and preeclampsia Obstet Gynecol 24 1964 350 356
28. I.A. Brosens, W.B. Robertson, and H.G. Dixon The role of the spiral arteries in the pathogenesis of preeclampsia Obstet Gynecol Annu 1 1972 177 191
29. I. Brosens, and M. Renaer On the pathogenesis of placental infarcts in pre-eclampsia J Obstet Gynaecol Br Commonw 79 1972 794 799
30. F. De Wolf, W.B. Robertson, and I. Brosens The ultrastructure of acute atherosis in hypertensive pregnancy Am J Obstet Gynecol 123 1975 164 174
31. W.B. Robertson, I. Brosens, and G. Dixon Uteroplacental vascular pathology Eur J Obstet Gynecol Reprod Biol 5 1975 47 65
32. W.B. Robertson, I. Brosens, and G. Dixon Maternal uterine vascular lesions in the hypertensive complications of pregnancy Perspect Nephrol Hypertens 5 1976 115 127
33. J.L. Kitzmiller, N. Watt, and S.G. Driscoll Decidual arteriopathy in hypertension and diabetes in pregnancy: immunofluorescent studies Am J Obstet Gynecol 141 1981 773 779
34. J. Hustin, J.M. Foidart, and R. Lambotte Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: light microscopy and immunofluorescence Placenta 4 1983 489 498
35. T.Y. Khong, F. De Wolf, W.B. Robertson, and I. Brosens Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants Br J Obstet Gynaecol 93 1986 1049 1059
36. T.Y. Khong, J.M. Pearce, and W.B. Robertson Acute atherosis in preeclampsia: maternal determinants and fetal outcome in the presence of the lesion Am J Obstet Gynecol 157 1987 360 363
37. T. Frusca, L. Morassi, S. Pecorelli, P. Grigolato, and A. Gastaldi Histological features of uteroplacental vessels in normal and hypertensive patients in relation to birthweight Br J Obstet Gynaecol 96 1989 835 839
38. T.Y. Khong Acute atherosis in pregnancies complicated by hypertension, small-for-gestational -Age infants, and diabetes mellitus Arch Pathol Lab Med 115 1991 722 725
39. J.W. Meekins, R. Pijnenborg, M. Hanssens, A. van Assche, and I.R. McFadyen Immunohistochemical detection of lipoprotein(a) in the wall of placental bed spiral arteries in normal and severe preeclamptic pregnancies Placenta 15 1994 511 524
40. J.S. Moldenhauer, J. Stanek, C. Warshak, J. Khoury, and B. Sibai The frequency and severity of placental findings in women with preeclampsia are gestational age dependent Am J Obstet Gynecol 189 2003 1173 1177
41. J.L. van der Merwe, D.R. Hall, C. Wright, P. Schubert, and D. Grove Are early and late preeclampsia distinct subclasses of the disease-what does the placenta reveal? Hypertens Pregnancy 29 2010 457 467
42. A.C. Staff, R. Dechend, and R. Pijnenborg Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health Hypertension 56 2010 1026 1034
43. G. Ogge, T. Chaiworapongsa, R. Romero, and et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia J Perinat Med 39 2011 641 652
44. E. Soto, R. Romero, J.P. Kusanovic, and et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti -Angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion J Matern Fetal Neonatal Med 25 2012 498 507
45. D.U. Stevens, S. Al-Nasiry, J. Bulten, and M.E. Spaanderman Decidual vasculopathy in preeclampsia: lesion characteristics relate to disease severity and perinatal outcome Placenta 34 2013 805 809
46. A.C. Staff, R. Dechend, and C.W. Redman Review: preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses Placenta 34 Suppl 2013 S73 S78
47. T. Chaiworapongsa, P. Chaemsaithong, L. Yeo, and R. Romero Pre-eclampsia part 1: current understanding of its pathophysiology Nat Rev Nephrol 10 2014 466 480
48. A.C. Staff, G.M. Johnsen, R. Dechend, and C.W. Redman Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors J Reprod Immunol 101-102 2014 120 126
49. K. Baltajian, J.L. Hecht, J.B. Wenger, and et al. Placental lesions of vascular insufficiency are associated with anti -Angiogenic state in women with preeclampsia Hypertens Pregnancy 33 2014 427 439
50. Y.M. Kim, P. Chaemsaithong, R. Romero, and et al. The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion J Matern Fetal Neonatal Med 28 2015 2001 2009
51. D.B. Nelson, M.S. Ziadie, D.D. McIntire, B.B. Rogers, and K.J. Leveno Placental pathology suggesting that preeclampsia is more than one disease Am J Obstet Gynecol 210 2014 66.e1 66.e7
52. Y.M. Kim, P. Chaemsaithong, R. Romero, and et al. Placental lesions associated with acute atherosis J Matern Fetal Neonatal Med 28 2015 1554 1562
53. M.J. Quinn Preeclampsia: 2 placental phenotypes, 1 etiology? Am J Obstet Gynecol 211 2014 313 314
54. D.B. Nelson, D.D. McIntire, and K.J. Leveno Reply: to PMID 24036400 Am J Obstet Gynecol 211 2014 314
55. M. McDonnold, G. Saade, and M. Costantine Reply: to PMID 24096182 Am J Obstet Gynecol 211 2014 572 573
56. I. Brosens, H.G. Dixon, and W.B. Robertson Fetal growth retardation and the arteries of the placental bed Br J Obstet Gynaecol 84 1977 656 663
57. F. De Wolf, I. Brosens, and M. Renaer Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension Br J Obstet Gynaecol 87 1980 678 685
58. B.L. Sheppard, and J. Bonnar An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation Br J Obstet Gynaecol 88 1981 695 705
59. C. Labarrere, J. Alonso, J. Manni, E. Domenichini, and O. Althabe Immunohistochemical findings in acute atherosis associated with intrauterine growth retardation Am J Reprod Immunol Microbiol 7 1985 149 155
60. O. Althabe, C. Labarrere, and M. Telenta Maternal vascular lesions in placentae of small-for-gestational -Age infants Placenta 6 1985 265 276
61. S.-Y. Park, H.S. Kim, M.Y. Kim, and et al. Placental pathology in intrauterine growth retardation Korean J Pathol 36 2002 30 37
62. M. Kovo, L. Schreiber, A. Ben-Haroush, and et al. The placental factor in early- and late-onset normotensive fetal growth restriction Placenta 34 2013 320 324
63. M. Parra-Saavedra, F. Crovetto, S. Triunfo, and et al. Placental findings in late-onset SGA births without Doppler signs of placental insufficiency Placenta 34 2013 1136 1141
64. S. Triunfo, S. Lobmaier, M. Parra-Saavedra, and et al. Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion Placenta 35 2014 398 403
65. W. Mifsud, and N.J. Sebire Placental pathology in early-onset and late-onset fetal growth restriction Fetal Diagn Ther 36 2014 117 128
66. M. Kovo, L. Schreiber, O. Elyashiv, A. Ben-Haroush, G. Abraham, and J. Bar Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia Reprod Sci 22 2015 316 321
67. M. Parra-Saavedra, S. Simeone, S. Triunfo, and et al. Correlation between histological signs of placental underperfusion and perinatal morbidity in late-onset small-for-gestational -Age fetuses Ultrasound Obstet Gynecol 45 2015 149 155
68. O. Hovatta, A. Lipasti, J. Rapola, and O. Karjalainen Causes of stillbirth: a clinicopathological study of 243 patients Br J Obstet Gynaecol 90 1983 691 696
69. F.J. Korteweg, J.J. Erwich, J.P. Holm, and et al. Diverse placental pathologies as the main causes of fetal death Obstet Gynecol 114 2009 809 817
70. U.M. Reddy, R. Goldenberg, R. Silver, and et al. Stillbirth classification-developing an international consensus for research: executive summary of a National Institute of Child Health and Human Development workshop Obstet Gynecol 114 2009 901 914
71. A.E. Heazell, and E.A. Martindale Can post-mortem examination of the placenta help determine the cause of stillbirth? J Obstet Gynaecol 29 2009 225 228
72. D. Kidron, J. Bernheim, and R. Aviram Placental findings contributing to fetal death, a study of 120 stillbirths between 23 and 40 weeks gestation Placenta 30 2009 700 704
73. H. Amir, A. Weintraub, B. Aricha-Tamir, L. Apel-Sarid, G. Holcberg, and E. Sheiner A piece in the puzzle of intrauterine fetal death: pathological findings in placentas from term and preterm intrauterine fetal death pregnancies J Matern Fetal Neonatal Med 22 2009 759 764
74. F. Shehata, I. Levin, A. Shrim, and et al. Placenta/birthweight ratio and perinatal outcome: a retrospective cohort analysis BJOG 118 2011 741 747
75. C.H. Tellefsen, and C. Vogt How important is placental examination in cases of perinatal deaths? Pediatr Dev Pathol 14 2011 99 104
76. L.R. Bonetti, P. Ferrari, N. Trani, and et al. The role of fetal autopsy and placental examination in the causes of fetal death: a retrospective study of 132 cases of stillbirths Arch Gynecol Obstet 283 2011 231 241
77. V. Flenady, P. Middleton, G.C. Smith, and et al. Stillbirths: the way forward in high-income countries Lancet 377 2011 1703 1717
78. L.B. Helgadottir, G. Turowski, F.E. Skjeldestad, and et al. Classification of stillbirths and risk factors by cause of death -A case-control study Acta Obstet Gynecol Scand 92 2013 325 333
79. H. Pinar, R.L. Goldenberg, M.A. Koch, and et al. Placental findings in singleton stillbirths Obstet Gynecol 123 2014 325 336
80. A.M. Roescher, A. Timmer, J.J. Erwich, and A.F. Bos Placental pathology, perinatal death, neonatal outcome, and neurological development: a systematic review PLoS One 9 2014 e89419
81. G. Altshuler, P. Russell, and R. Ermocilla The placental pathology of small-for-gestational age infants Am J Obstet Gynecol 121 1975 351 359
82. R. Salim, J. Jubran, M. Okopnik, and G. Garmi Do placental lesions among term small for gestational age newborns differ according to the clinical presentation? Eur J Obstet Gynecol Reprod Biol 173 2014 38 42
83. M. Parra-Saavedra, F. Crovetto, S. Triunfo, and et al. Association of Doppler parameters with placental signs of underperfusion in late-onset small-for-gestational -Age pregnancies Ultrasound Obstet Gynecol 44 2014 330 337
84. D. Getahun, Y. Oyelese, H.M. Salihu, and C.V. Ananth Previous cesarean delivery and risks of placenta previa and placental abruption Obstet Gynecol 107 2006 771 778
85. Institute of Medicine. Preterm birth: causes, consequences, and prevention 2007 National Academies Press Washington (DC)
86. C.J. Berg, W.M. Callaghan, C. Syverson, and Z. Henderson Pregnancy-related mortality in the United States, 1998 to 2005 Obstet Gynecol 116 2010 1302 1309
87. M.K. Mwaniki, M. Atieno, J.E. Lawn, and C. Newton Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review Lancet 379 2012 445 452
88. F. Arias, L. Rodriquez, S.C. Rayne, and F.T. Kraus Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes Am J Obstet Gynecol 168 1993 585 591
89. Y.M. Kim, T. Chaiworapongsa, R. Gomez, and et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes Am J Obstet Gynecol 187 2002 1137 1142
90. Y.M. Kim, E. Bujold, T. Chaiworapongsa, and et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes Am J Obstet Gynecol 189 2003 1063 1069
91. M. Kovo, L. Schreiber, A. Ben-Haroush, and et al. The placental factor in spontaneous preterm labor with and without premature rupture of membranes J Perinat Med 39 2011 423 429
92. J. Armstrong-Wells, M.D. Post, M. Donnelly, M.J. Manco-Johnson, B.M. Fisher, and V.D. Winn Patterns of placental pathology in preterm premature rupture of membranes J Dev Orig Health Dis 4 2013 249 255
93. R. Kelly, C. Holzman, P. Senagore, and et al. Placental vascular pathology findings and pathways to preterm delivery Am J Epidemiol 170 2009 148 158
94. R.L. Goldenberg, J.F. Culhane, J.D. Iams, and R. Romero Preterm birth 1-epidemiology and causes of preterm birth Lancet 371 2008 75 84
95. R. Romero Prenatal medicine: the child is the father of the man. 1996 J Matern Fetal Neonatal Med 22 2009 636 639
96. G.C. Di Renzo The great obstetrical syndromes J Matern Fetal Neonatal Med 22 2009 633 635
97. T. Chaiworapongsa, R. Romero, J. Espinoza, and et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award Am J Obstet Gynecol 190 2004 1541 1550
98. T. Chaiworapongsa, R. Romero, Y.M. Kim, and et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia J Matern Fetal Neonatal Med 17 2005 3 18
99. C.W. Park, J.S. Park, S.S. Shim, J.K. Jun, B.H. Yoon, and R. Romero An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia Am J Obstet Gynecol 193 2005 984 989
100. E. Bujold, R. Romero, T. Chaiworapongsa, and et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin J Matern Fetal Neonatal Med 18 2005 9 16
101. S. Venkatesha, M. Toporsian, C. Lam, and et al. Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 2006 642 649
102. O. Erez, R. Romero, J. Espinoza, and et al. The change in concentrations of angiogenic and anti -Angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age J Matern Fetal Neonatal Med 21 2008 279 287
103. R. Romero, J.K. Nien, J. Espinoza, and et al. A longitudinal study of angiogenic (placental growth factor) and anti -Angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate J Matern Fetal Neonatal Med 21 2008 9 23
104. T. Chaiworapongsa, R. Romero, F. Gotsch, and et al. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age J Matern Fetal Neonatal Med 21 2008 41 52
105. J.P. Kusanovic, R. Romero, T. Chaiworapongsa, and et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti -Angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia J Matern Fetal Neonatal Med 22 2009 1021 1038
106. T. Chaiworapongsa, R. Romero, A.L. Tarca, and et al. A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia Am J Obstet Gynecol 202 2010 550.e1 550.e10
107. T. Chaiworapongsa, R. Romero, Z.A. Savasan, and et al. Maternal plasma concentrations of angiogenic/anti -Angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia J Matern Fetal Neonatal Med 24 2011 1187 1207
108. R. Romero, and T. Chaiworapongsa Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state J Clin Invest 123 2013 2775 2777
109. T. Chaiworapongsa, R. Romero, S.J. Korzeniewski, and et al. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia Am J Obstet Gynecol 208 2013 287.e1 287.e15
110. T. Chaiworapongsa, R. Romero, S.J. Korzeniewski, and et al. Plasma concentrations of angiogenic/anti -Angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study J Matern Fetal Neonatal Med 27 2014 132 144
111. T. Chaiworapongsa, P. Chaemsaithong, S.J. Korzeniewski, L. Yeo, and R. Romero Pre-eclampsia part 2: prediction, prevention and management Nat Rev Nephrol 10 2014 531 540
112. T. Chaiworapongsa, R. Romero, A. Tarca, and et al. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti -Angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study J Matern Fetal Neonatal Med 22 2009 1122 1139
113. J. Espinoza, T. Chaiworapongsa, R. Romero, and et al. Unexplained fetal death: another anti -Angiogenic state J Matern Fetal Neonatal Med 20 2007 495 507
114. R. Romero, T. Chaiworapongsa, O. Erez, and et al. An imbalance between angiogenic and anti -Angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study J Matern Fetal Neonatal Med 23 2010 1384 1399
115. A.E. Whitten, R. Romero, S.J. Korzeniewski, and et al. Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death Am J Obstet Gynecol 208 2013 310.e1 310.e11
116. J.P. Kusanovic, R. Romero, J. Espinoza, and et al. Twin-to-twin transfusion syndrome: an antiangiogenic state? Am J Obstet Gynecol 198 2008 382.e1 382.e8
117. M.D. Savvidou, C.K. Yu, L.C. Harland, A.D. Hingorani, and K.H. Nicolaides Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction Am J Obstet Gynecol 195 2006 1668 1673
118. T. Chaiworapongsa, J. Espinoza, F. Gotsch, and et al. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation J Matern Fetal Neonatal Med 21 2008 25 40
119. R. Prentice A case-cohort design for epidemiologic cohort studies and disease prevention trials Biometrika 73 1986 1 11
120. G.R. Alexander, J.H. Himes, R.B. Kaufman, J. Mor, and M. Kogan A United States national reference for fetal growth Obstet Gynecol 87 1996 163 168
121. R.W. Redline, D. Heller, S. Keating, and J. Kingdom Placental diagnostic criteria and clinical correlation -A workshop report Placenta 26 Suppl 2005 S114 S117
122. G. Ogge, R. Romero, D.C. Lee, and et al. Chronic chorioamnionitis displays distinct alterations of the amniotic fluid proteome J Pathol 223 2011 553 565
123. B.M. Sibai, M. Ewell, R.J. Levine, and et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group Am J Obstet Gynecol 177 1997 1003 1010
124. P. von Dadelszen, L.A. Magee, and J.M. Roberts Subclassification of preeclampsia Hypertens Pregnancy 22 2003 143 148
125. M.F. Macdorman, and S. Kirmeyer The challenge of fetal mortality NCHS Data Brief 2009 1 8
126. Koenker, R. (2007). quantreg: Quantile Regression. R package version 4.10.
127. Koenker RW. Quantile regression. Cambridge University Press; Cambridge, 2005.
128. Team, R. D. C. R Foundation for Statisical Computing; Vienna, Austria: 2009. R: A language and environment for statisical computing.
129. D.S. Torry, H.S. Wang, T.H. Wang, M.R. Caudle, and R.J. Torry Preeclampsia is associated with reduced serum levels of placenta growth factor Am J Obstet Gynecol 179 1998 1539 1544
130. SAS, version 9.4. SAS Institute Cary, NC, USA; 2013.
131. A. Reuvekamp, F.V. Velsing-Aarts, I.E. Poulina, J.J. Capello, and A.J. Duits Selective deficit of angiogenic growth factors characterizes pregnancies complicated by pre-eclampsia Br J Obstet Gynaecol 106 1999 1019 1022
132. S.C. Tidwell, H.N. Ho, W.H. Chiu, R.J. Torry, and D.S. Torry Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia Am J Obstet Gynecol 184 2001 1267 1272
133. S.E. Maynard, J.Y. Min, J. Merchan, and et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
134. R.N. Taylor, J. Grimwood, R.S. Taylor, M.T. McMaster, S.J. Fisher, and R.A. North Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies Am J Obstet Gynecol 188 2003 177 182
135. V. Tsatsaris, F. Goffin, C. Munaut, and et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences J Clin Endocrinol Metab 88 2003 5555 5563
136. A. Luttun, and P. Carmeliet Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? J Clin Invest 111 2003 600 602
137. K. Koga, Y. Osuga, O. Yoshino, and et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia J Clin Endocrinol Metab 88 2003 2348 2351
138. R.J. Levine, S.E. Maynard, C. Qian, and et al. Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
139. R.J. Levine, C. Lam, C. Qian, and et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 2006 992 1005
140. C.J. Robinson, D.D. Johnson, E.Y. Chang, D.M. Armstrong, and W. Wang Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia Am J Obstet Gynecol 195 2006 255 259
141. E.R. Unal, C.J. Robinson, D.D. Johnson, and E.Y. Chang Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia Am J Obstet Gynecol 197 2007 211.e1 211.e4
142. M.D. Lindheimer, and R. Romero Emerging roles of antiangiogenic and angiogenic proteins in pathogenesis and prediction of preeclampsia Hypertension 50 2007 35 36
143. T.A. Moore Simas, S.L. Crawford, M.J. Solitro, S.C. Frost, B.A. Meyer, and S.E. Maynard Angiogenic factors for the prediction of preeclampsia in high-risk women Am J Obstet Gynecol 197 2007 244.e1 244.e8
144. M. Widmer, J. Villar, A. Benigni, A. Conde-Agudelo, S.A. Karumanchi, and M. Lindheimer Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review Obstet Gynecol 109 2007 168 180
145. A. De Vivo, G. Baviera, D. Giordano, G. Todarello, F. Corrado, and R. D'Anna Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia Acta Obstet Gynecol Scand 87 2008 837 842
146. A. Molvarec, A. Szarka, S. Walentin, E. Szucs, B. Nagy, and J. Rigo Jr. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia Hypertens Res 33 2010 892 898
147. R.W. Powers, A. Jeyabalan, R.G. Clifton, and et al. Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies PLoS One 5 2010 e13263
148. S. Rana, M.R. Hacker, A.M. Modest, and et al. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia Hypertension 60 2012 451 458
149. V.D. Garovic The role of angiogenic factors in the prediction and diagnosis of preeclampsia superimposed on chronic hypertension Hypertension 59 2012 555 557
150. S.K. Ghosh, S. Raheja, A. Tuli, C. Raghunandan, and S. Agarwal Serum PLGF as a potential biomarker for predicting the onset of preeclampsia Arch Gynecol Obstet 285 2012 417 422
151. H. Hagmann, R. Thadhani, T. Benzing, S.A. Karumanchi, and H. Stepan The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia Clin Chem 58 2012 837 845
152. S. Verlohren, H. Stepan, and R. Dechend Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia Clin Sci (Lond) 122 2012 43 52
153. S. Rana, A.S. Cerdeira, J. Wenger, and et al. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia PLoS One 7 2012 e48259
154. J. Sibiude, J. Guibourdenche, M.D. Dionne, and et al. Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction PLoS One 7 2012 e50208
155. L.J. Vatten, B.O. Asvold, and A. Eskild Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction Acta Obstet Gynecol Scand 91 2012 1388 1394
156. T.F. McElrath, K.H. Lim, E. Pare, and et al. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy Am J Obstet Gynecol 207 2012 407.e1 407.e7
157. S. Rana, C.E. Powe, S. Salahuddin, and et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia Circulation 125 2012 911 919
158. A.G. Moore, H. Young, J.M. Keller, and et al. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia J Matern Fetal Neonatal Med 25 2012 2651 2657
159. P.K. Aggarwal, N. Chandel, V. Jain, and V. Jha The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia J Hum Hypertens 26 2012 236 241
160. L.C. Chappell, S. Duckworth, P.T. Seed, and et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study Circulation 128 2013 2121 2131
161. S. Verlohren, I. Herraiz, O. Lapaire, and et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia Hypertension 63 2014 346 352
162. A. Goel, and S. Rana Angiogenic factors in preeclampsia: potential for diagnosis and treatment Curr Opin Nephrol Hypertens 22 2013 643 650
163. T.A. Moore Simas, S.L. Crawford, S. Bathgate, and et al. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women J Matern Fetal Neonatal Med 27 2014 1038 1048
164. D. Rizos, M. Eleftheriades, G. Karampas, and et al. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study Eur J Obstet Gynecol Reprod Biol 171 2013 225 230
165. W. Schaarschmidt, S. Rana, and H. Stepan The course of angiogenic factors in early- vs late-onset preeclampsia and HELLP syndrome J Perinat Med 41 2013 511 516
166. S.E. Maynard, S.L. Crawford, S. Bathgate, and et al. Gestational angiogenic biomarker patterns in high risk preeclampsia groups Am J Obstet Gynecol 209 2013 18
167. K. Gray, K.H. Lim, A. Thomas, S. Parry, and T.F. McElrath Maternal plasma levels of PlGF and sFlt-1 change throughout the 1st trimester and correlate with development of early-onset pre-eclampsia (abstract 633) Am J Obstet Gynecol 208 2013 S268 S269
168. T.D. Metz, A.A. Allshouse, A.G. Euser, and K.D. Heyborne Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers Am J Obstet Gynecol 211 2014 23
169. G.C. Smith, J.A. Crossley, D.A. Aitken, and et al. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth Obstet Gynecol 109 2007 1316 1324
170. T. Chaiworapongsa, J.P. Kusanovic, Z.A. Savasan, and et al. Fetal death: a condition with a dissociation in the concentrations of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments J Matern Fetal Neonatal Med 23 2010 960 972
171. F. Gotsch, R. Romero, J.P. Kusanovic, and et al. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2 J Matern Fetal Neonatal Med 21 2008 389 402
172. B.O. Asvold, L.J. Vatten, P.R. Romundstad, P.A. Jenum, S.A. Karumanchi, and A. Eskild Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction Am J Epidemiol 173 2011 630 639
173. A.M. Darling, C.R. McDonald, A.L. Conroy, and et al. Angiogenic and inflammatory biomarkers in midpregnancy and small-for-gestational -Age outcomes in Tanzania Am J Obstet Gynecol 211 2014 509.e1 509.e8
174. S.M. Lobmaier, F. Figueras, I. Mercade, and et al. Angiogenic factors vs Doppler surveillance in the prediction of adverse outcome among late-pregnancy small-for-gestational -Age fetuses Ultrasound Obstet Gynecol 43 2014 533 540
175. A.M. Darling, C.R. McDonald, A.L. Conroy, and et al. Angiogenic and inflammatory biomarkers in midpregnancy and small-for-gestational -Age outcomes in Tanzania Am J Obstet Gynecol 211 2014 29
176. S. Mullers, J. Untersheider, E. Doyle, and et al. Placental lesions in pregnancies complicated by intrauterine growth restriction and hypertension (abstract 338) Am J Obstet Gynecol 210 2014 S174 S175
177. T. Chaiworapongsa, R. Romero, S.J. Korzeniewski, and et al. Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD) J Matern Fetal Neonatal Med 29 2016 855 862
178. C.E. Fox, G.E. Lash, S.J. Pretlove, B.C. Chan, R. Holder, and M.D. Kilby Maternal plasma and amniotic fluid angiogenic factors and their receptors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome Ultrasound Obstet Gynecol 35 2010 695 701
179. Y. Yinon, E. Ben Meir, A. Berezowsky, and et al. Circulting angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction Am J Obstet Gynecol 210 2014 18
180. J. Espinoza, R. Romero, J.K. Nien, and et al. A role of the anti -Angiogenic factor sVEGFR-1 in the 'mirror syndrome' (Ballantyne's syndrome) J Matern Fetal Neonatal Med 19 2006 607 613
181. G. Ogge, T. Chaiworapongsa, R. Romero, and et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia J Perinat Med 39 2011 641 652
182. F. Arias, A. Victoria, K. Cho, and F. Kraus Placental histology and clinical characteristics of patients with preterm premature rupture of membranes Obstet Gynecol 89 1997 265 271
183. N.J. Sebire, R.D. Goldin, and L. Regan Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity J Obstet Gynaecol 25 2005 117 118
184. L. Apel-Sarid, A. Levy, G. Holcberg, and E. Sheiner Term and preterm (<34 and <37 weeks gestation) placental pathologies associated with fetal growth restriction Arch Gynecol Obstet 282 2010 487 492
185. R.S. Mijal, C.B. Holzman, S. Rana, S.A. Karumanchi, J.L. Wang, and A. Sikorskii Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery J Matern Fetal Neonatal Med 25 2012 1135 1141
186. F.T. Kraus, R. Redline, D.J. Gersell, M.D. Nelson, and J.M. Dicke Placental pathology 1st ed. 2004 American Registry of Pathology Washington (DC)